702 Results

People

  1. Motzer
    Motzer
  2. Livingston
    Livingston
  3. Norton
    Norton
  4. Aghajanian
    Aghajanian
  5. Hudis
    Hudis
  6. Krown
    Krown
  7. Sepkowitz
    Sepkowitz
  8. O'Reilly
    O'Reilly
  9. Panageas
    Panageas
  10. Horwitz
    Horwitz

Groups

  1. Department of Medicine (450)
  2. Solid Tumor Oncology Division (259)
  3. Hematologic Malignancies, Division of (178)
  4. Center for Hematologic Malignancies (151)
  5. Surgery (92)
  6. Survivorship Research (88)
  7. Epidemiology and Biostatistics (73)
  8. GSK Faculty (73)
  9. Division of Subspecialty Medicine (65)
  10. Gastrointestinal Oncology Service (64)
  1. "fever"
Formats
  1. Journal Article (657)
  2. Review (23)
  3. Conference Paper (6)
  4. Research Letter (6)
  5. Guidelines (5)
  6. Editorial (4)
  7. Correspondence (1)
Groups
  1. Department of Medicine (450)
  2. Solid Tumor Oncology Division (259)
  3. Hematologic Malignancies, Division of (178)
  4. Center for Hematologic Malignancies (151)
  5. Surgery (92)
  6. Survivorship Research (88)

More Groups

People
  1. Robert Motzer (24)
  2. Larry Norton (20)
  3. Philip Livingston (19)
  4. Carol Aghajanian (17)
  5. Clifford Hudis (17)
  6. Kent Sepkowitz (17)

More People

Years
  1. 2025 (21)
  2. 2024 (42)
  3. 2023 (40)
  4. 2022 (22)
  5. 2021 (25)
  6. 2020 (44)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Clinical Cancer Research (33)
  3. Blood (22)
  4. Lancet Oncology (22)
  5. Cancer (21)
  6. New England Journal of Medicine (18)

More Publications

Publishers
  1. Elsevier Inc. (107)
  2. American Society of Clinical Oncology (70)
  3. Elsevier Science, Inc. (55)
  4. Springer (53)
  5. Nature Publishing Group (40)
  6. Wiley Blackwell (38)

More Publishers

Results (702)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; Oudard, S.; Negrier, S.; Szczylik, C.; Pili, R.; Bjarnason, G. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Safely prescribing nirmatrelvir and ritonavir - Avoiding drug-drug interactions
    Journal Article

    Culas, R.; Nath, S.; Nath, S.
    JAMA Internal Medicine (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: A phase II, open-label, multicenter, multicohort study
    Journal Article

    Sherman, E.; Lee, J. L.; Debruyne, P. R.; Keam, B.; Shin, S. J.; Gramza, A.; Caro, I.; Amin, R.; Shah, K.; Yan, Y.; more...
    ESMO Open (2023)

    Fulltext@MSK | Save
  • CE: Febrile neutropenia in the chemotherapy patient
    Review

    Foley, A. M.; Hoffman, M.
    American Journal of Nursing (2023)

    Fulltext@MSK | Save
  • Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: Longer-term follow-up of ASCEMBL
    Journal Article

    Hochhaus, A.; Réa, D.; Boquimpani, C.; Minami, Y.; Cortes, J. E.; Hughes, T. P.; Apperley, J. F.; Lomaia, E.; Voloshin, S.; Turkina, A.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Bacterial infections and antibiotic utilization varies by coronavirus disease 19 (COVID-19) severity in hospitalized cancer patients: Analysis from the first phase of the pandemic
    Journal Article

    Maki, K. R.; Steiger, S. N.; Su, Y.; Boumiza, A.; Tan, C. A.; Kerpelev, M.; Seo, S. K.; Cohen, N.
    Infection Control and Hospital Epidemiology (2023)

    Fulltext@MSK | Save
  • Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer
    Journal Article

    Yoshino, T.; Andre, T.; Kim, T. W.; Yong, W. P.; Shiu, K. K.; Jensen, B. V.; Jensen, L. H.; Punt, C. J. A.; Smith, D.; Garcia-Carbonero, R.; more...
    Cancer Science (2023)

    Fulltext@MSK | Save
  • Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma
    Journal Article

    Chintala, N. K.; Choe, J. K.; McGee, E.; Bellis, R.; Saini, J. K.; Banerjee, S.; Moreira, A. L.; Zauderer, M. G.; Adusumilli, P. S.; Rusch, V. W.
    Frontiers in Immunology (2023)

    Fulltext@MSK | Save
  • OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
    Journal Article

    Robson, M. E.; Im, S. A.; Senkus, E.; Xu, B.; Domchek, S. M.; Masuda, N.; Delaloge, S.; Tung, N.; Armstrong, A.; Dymond, M.; more...
    European Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer
    Journal Article

    Rudin, C. M.; Cervantes, A.; Dowlati, A.; Besse, B.; Ma, B.; Costa, D. B.; Schmid, P.; Heist, R.; Villaflor, V. M.; Spahn, J.; more...
    ESMO Open (2023)

    Fulltext@MSK | Save